[Developmental and involutional breast disorders]

Lijecnicki vjesnik · 1994 · vol. 114(5-8) , pp. 105–9 · PMID:1343037 · W2407208721
Other OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-08 ⓘ

This study evaluated treatments for cyclic and noncyclic mastalgia in sixty women and histologically examined benign breast tissue in one hundred forty-five patients, finding that atypical hyperplasia significantly increases breast cancer risk.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The majority of benign breast disorders may be classified as developmental and involutive. Mastalgia and breast nodularity represent the greatest groups of these disorders, while epithelial hyperplasia is a complex benign disorder which is most difficult to be evaluated. Sixty women with diagnosis of cyclic mastalgia and 30 with noncyclic breast pain were followed-up. Patients were administered bromocryptine, danazol or a local progestogel. Better treatment results were achieved in cyclic mastalgia than in women with noncyclic mastalgia. One hundred and forty-five biopsies of the benign breast tissue were examined histologically. Nonproliferative forms were found in 66.9% of the women, proliferative without atypia in 29.65%, and proliferative with atypia in 3.45% of the patients. Atypical ductal hyperplasia and atypical lobular hyperplasia increase four-to fivefold the risk for breast cancer. Prophylactic subcutaneous or total mastectomy is not as a rule indicated in atypical epithelial hyperplasia, only regular follow-up is required.

My notes (saved in your browser only)

MeSH descriptors

Breast Diseases Breast Diseases Breast Diseases Adult Female Humans Middle Aged Pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:57:58.569128+00:00
pubmed
last seen: 2026-10-08T21:01:29.034871+00:00
License: CC0 · commercial use OK